CTRI/2013/12/004231招募中3 期
Multicentric Open labeled clinical trial on Neerizhivu (Diabetes mellitus) - MCOCD5
Central Council for Research in Siddha0 个研究点目标入组 90 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •males or females with a diagnosis of type 2 diabetes mellitus. Diabetes defined as those patients with fasting glucose levels of 110 mg/dl to 200 mg/dl and post prandial blood glucose 160 mg/dl to 350 mg/dl or HbA1c 6.5% to 10%
排除标准
- •Malignant and accelerated hypertensive
- •CVS disorder (CAD)
- •Pregnant woman or the women planning to be pregnant in next six months
- •Lactating mothers
- •Secondary Diabetes mellitus
- •Patient undergoing regular treatment for Diabetes or for any other severe illness
- •CNS disorder e.g. encephalopathy
研究者
相似试验
尚未招募
3 期
A trial to study efficacy of FFDP capsules in diabetic patientsCTRI/2021/12/038559Viridis BioPharma Pvt Ltd
已完成
不适用
Performance of the medical device LHAC1 (hyaluronic acid - collagenase) for the management of chronic venous ulcersChronic venous ulcersCirculatory SystemISRCTN12579869Fidia Pharmaceutical [Fidia Farmaceutici S.p.A.] (Italy)100
进行中（未招募）
1 期
A Clinical Trial to be conducted in many hospitals and in different countries with the medicinal substance Nivolumab as the only therapy in patients with Non-Small Cell Lung Cancer (NSCLC) who have received earlier cancer treatments.Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 21.1 Level: PT Classification code 10059515 Term: Non-small cell lung cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001285-10-GBBristol-Myers Squibb International Corporation950
进行中（未招募）
1 期
A Clinical Trial to be conducted in many hospitals and in different countries with the medicinal substance Nivolumab as the only therapy in patients with Non-Small Cell Lung Cancer (NSCLC) who have received earlier cancer treatments.Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 21.1Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001285-10-FIBristol-Myers Squibb International Corporation950
进行中（未招募）
1 期
A Clinical Trial to be conducted in many hospitals and in different countries with the medicinal substance Nivolumab as the only therapy in patients with Non-Small Cell Lung Cancer (NSCLC) who have received earlier cancer treatments.Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC)MedDRA version: 20.0Level: PTClassification code 10059515Term: Non-small cell lung cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-001285-10-SEBristol-Myers Squibb International Corporation950